IL42007A - 2-benzoyl-3-amino-pyridines - Google Patents
2-benzoyl-3-amino-pyridinesInfo
- Publication number
- IL42007A IL42007A IL42007A IL4200773A IL42007A IL 42007 A IL42007 A IL 42007A IL 42007 A IL42007 A IL 42007A IL 4200773 A IL4200773 A IL 4200773A IL 42007 A IL42007 A IL 42007A
- Authority
- IL
- Israel
- Prior art keywords
- carbon atoms
- hydrogen
- alkyl
- benzoyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
There are prepared compounds of the formula WHERE R1 is halogen, R2 and R3 are hydrogen, halogen, trifluoromethyl, hydroxy, cyano, lower alkyl or lower alkoxy, R4 is hydrogen or lower alkyl, and R5 is hydrogen, lower alkyl, benzoyl, substituted benzoyl, lower carbalkoxy or WHERE A is oxygen, sulfur, imino or lower alkylimino and R6 is lower alkyl, lower alkyl having 1 to 3 halogen atoms, lower alkenyl, hydroxymethyl, carboxymethyl, carb-lower alkoxy methyl, amino lower alkyl or alkylaminoalkyl having 2 to 13 carbon atoms or where any hydroxy or primary or secondary amino group is substituted by an alkanoyl group of 2 to 8 carbon atoms, carbalkoxy having 1 to 6 carbon atoms, carbophenoxy or carbobenzyloxy or a pharmacologically acceptable salt thereof. The compounds are useful in emotional disturbances, tension, anxiety, increased irritability.
[US3875176A]
Description
New 2-bQnzo5rl~3-9.iai o~ yFidin©s Deutsche Gold- und Silber^Seheideans alt normals Roessler C:-39843 ABSTRACT OF THE DISCLOSURE There are prepared compounds of the formula where R halogen, trifluoromethyl, hydroxy, cyano, lower alkyl or lower alkoxy, R is hydrogen or lower alkyl, and R is hydrogen, lower alkyl, benzoyl, substituted benzoyl, lower carbalkoxy or A —C R 6-where A is oxygen, sulfur, imino or lower alkylimino and R β is lower alkyl, lower alkyl havinglto3 halogen atoms, lower alkenyl, hydroxymethyl, carboxymethyl, carb -lower alkoxy methyl, amino lower alkyl or alkylaminoalkyl having 2 to 13 carbon atoms or where any hydroxy or primary or secondary amino group is substituted by an alkanoyl group of 2 to 8 carbon atoms, carbalkoxy having 1 to 6 carbon atoms, carbophenoxy or carbobenzyloxy or a pharmacologically acceptable salt thereof. The compounds are useful in emotional disturbances, tension, anxiety, increased irritability. They also serve as intermediates in the preparation of drugs, e.g. such as are described- in Israel Patent Specification No. 41034· The invention consists in compounds of the formula wherein is halogen, R2 and are hydrogen, halogen or lower alkyl; R^ is hydrogen or lower 11.4-73 alkyl, and R,. is hydrogen, lower alkyl, benzoyl, halo for underlined ·, meanings substituted benzoyl, lower carbalkoxy or alkyl having 1 to 3 halogen atoms as substituents, lower alkenyl , aminolower alkyl or alkylaminoalkyl having 2 to 13 carbon atoms or where any primary or secondary amino group has the hydrogen replaced by an alkanoyl group of 2 to 8 carbon atoms , carbalkoxy having 1 to 6 carbon atoms in the alkoxy group or carbobenzyloxy and pharmacologically acceptable salts of such compounds.
: .. .. ■ * ■ The compounds are useful in emotional disturbances, tension, anxiety, increased irritability.
They also serve as intermediates in the preparation of drugs, e.g. such as are described in Israel Patent Specification No. 41034. 42007/2 As halogens there are employed chlorine, fluorine and bromine, i.e. halogens of atomic weight to 8°^· especially chlorine and bromine. In the above named lower alkyl, alkenyl, alkylamino, alkanoyl and carbalkoxy groups preferably there are present 1 to 6 carbon atoms (2 to 6 carbon atoms for the alkenyl group), especially 1 to H carbon atoms (2 to 1 carbon atoms for the alkenyl group). (This is also true if these C ovpp jsva I ^ι» +hn r^mpTnr) with a further chemical radical designation such as for example, carbalkoxymethyl and aminoalkyl). These groups, especially the alkyl and alkenyl groups can be straight or branched chain. The halo substituted benzoyl group (R ) is substituted in the phenyl 5 nucleus with one to three (o, m, or p- positions) halogen atoms, especially chlorine, bromine or fluorine. Preferably, the substituents are in the o- and p- positions. The halogen substituted alkyl groups can have 2 or 3 halogen atoms, for example, fluorine atoms on the same carbon atoms as is the case for example with the trifluoroace tyl group.
An especially preferred group of compounds within formula I is that wherein R^ is chlorine, Rg is hydrogen or halogen, is hydrogen, R^ is hydrogen or alkyl with 1 to 3 carbon atoms and s is hydrogen or an aliphatic acyl group of 2 to 4 carbon atoms or an aliphatically unsaturated acyl group with 3 to 5 carbon atoms, (e.g. ethylenically unsaturated), a haloacetyl group, an aminoacetyl group, a carbomethoxy group, a carbethoxy group or a benzoyl group.
Even more preferred are compounds of formula I where R^ is chlorine, R^ is hydrogen, chlorine or fluorine, ^ is hydrogen, jj. is h dro e ~c^—methyl,"~E^ is hydrogen, acetyl, propionyl, chloroacetyl, bromoacetyl or aminoacetyl.
In addition to the0 compounds mentioned in the specif working examples, there can also be made by the same procedure other compounds within the invention such as 2-benzoyl-3-amino 6-fluoropyridine, 2-benzoyl-3-amino-6-bromo-pyridine, 2-benzoy -3-(3>3-dimethyl-acryloxylamino)-6-bromopyridine, 2-benzoyl--3-benzoylamino-6-fluoro-pyridine, 2-(p-chlorobenzoyl -3-amino-6-chloro-pyridine, 2-(m-chlorobenzoyl)-3-amino-6-chloropyridine, 2-(o-broriiobenzoyl)-3-amino-6-chloropyridine, 2-(p-bromobenzoyl) -3-amino-6-bromo-pyridine, 2-(o-fluorobenzoyl)-3-amino-6-fluor pyridine, 2-(o-chlorobenzoyl)-3-methylamino)-6-chloropyridine, 2-benzoyl-3-chloroacetylamino-6-chloro-pyridine, 2-benzoyl-3-bromoacetyl-amino-6-chloro-pyridine, 2-benzoyl-3-ethylamino-6-chloropyridine, 2-(o-chlorobenzoyl)-3-isopropylamino-6-chloro-pyridine, 2-benzoyl-3- -propylamino-6-bromopyridlne, 2-benzoyl 42007/2 -3-butyrylamino-6-chloropyrIdine, 2-benzoyl-3-acryloylamino-6 chloropyridine, 2-benzoyl-3- (methacryloyl ethylamino) -6-chlor pyridine, 2-benzoyl-3-carbmethoxyamino-6-chloro-pyridIne3 2- benzoyl-S-carbethoxy-methylamino^-e-chlor'opyridine, | 2-benzoyl-3-trifluoroacetyl- amino-6-chloropyridine_, 2-benzoyl-3-carbophenoxyamino-6-chlor pyridine, 2-benzoyl-3-carboamyloxy-6-chloropyridine, 2-benzoyl -3- (beta-chloropropionyl-amino-6-chloropyridine, 2-benzoyl-3-_dihexylamino-6-chloropyridine, ! 2-benzoyl-3-(2-chloro-acryloylamino)-6-chloropyridine, 2-benz -3-ethyliminoamino-6-chloropyridinej There can be prepared and used the salts with pharmacologically acceptable acids such as hydrochloric acid, hydrobromic acid, succinic acid, tartaric acid, fumaric acid, sulfuric acid, citric acid, phosphoric acid, lactic acid, malonic acid, maleic acid, acetic acid, propionic acid and p-toluenesulfonic acid.
The compounds of the invention have valuable pharmacodynamic properties. Especially they have marked sedative, psychosedative and anxiolytic properties as well as antiphlo-gistic properties.
The new compounds can be prepared by methods which are known in themselves.
The methods of preparing the compounds include (a) Reacting a compound of formula I where R^ is hydrogen and Rtj is hydrogen or a lower alkyl group with a compound of the formula where A and g are as defined above and E is a halogen, especial ly chlorine or bromine, a hydroxy group or an acylated hydroxy or reacting with aliphatic lactones containing 3-8 carbon atoms, or (b) In a compound of the general formmla I converting the compound where R and/or R are as defined above or R is also another acyl group as is customarily used in peptide chemistry is converted to another compound of formula I by alkyla ion, acylation, saponification, catalytic hydrogenation or reaction with phosphorus pentasulfide or ammonia or a lower monoalkyl-amine having 1-6 carbon atoms, or (c) in compounds of formula III wherein Ri^ R≥ and R^ are as defined above reducing the nitro group to an amino group and in a given case alkylating the amino group formed with a lower alkyl group and/or with a compound of formula II or acylating with an aliphatic lactone of 3 to 8 carbon atoms.
Process (a) Process (a) is suitably carried out in a solvent such as an aliphatic alcohol, e.g. methyl alcohol, ethyl alcohol isopropyl alcohol or butyl alcohol, dioxane tetrahydrofurane, dimethyl sulfoxide or dimethyl formamide at a temperature between 0 and 150°C. The process can be carried out in the presence of basic materials such as pyridine, quinoline, tri-ethylamine, diisopropylamine, potassium carbonate and sodium carbonate, etc. In case E is an acylated hydroxy group, especially preferred acyl groups are those derived from lower saturated aliphatic carboxylic acids having 2 to 6 carbon atoms, as, for example, the acetyl, hexanoyl and propionyl groups.
In the case where E is a hydroxy group the reaction is undertaken in the presence of known condensation agents such as dicyclohexylcarbodiimide, diimidazolylcarbonyl 1,2-dihydroquinoline or N-ethoxycarbonyl-2-ethoxy-l,2-dihydroquinoli If lactones are used the reaction takes place, for example, in inert organic solvents at temperatures between 20 - 250°C, in a given case with the use of conventional condensation agents. Preferably beta or gamma lactones are used.
Examples of suitable compounds within formula II are acetyl chloride, acetyl bromide, thioacetyl chloride, propionyl chloride, propionyl bromide, thiopropionyl bromide, hexanoyl . chloride, thiohexanoyl chloride, butyryl chloride, octanoyl chloride, chloroacetyl chloride, chloropropionyl chloride, bromoacetyl chloride, acryloyl chloride, acryloyl bromide, 2-chloroacryloyl chloride, methacryloyl chloride, 3,3-dimethyl-acryloyl chloride, methyl chloroformate, ethyl chloroformate, hexyl chloroformate, benzoyl chloride, benzoyl bromide, acetic acid, propionic acid, hexanoic acid, aminoacetyl chloride, glycine beta-aminopropionic acid, omega-amino-hexanoic acid, omega-aminoctanoic acid.
Process (b) One or two lower alkyl groups are introduced by alkylation into compounds of formula I in which both and are hydrogen or one of these groups is hydrogen. As alkylating agents there can be used, for example, esters of the formulae R*5 Hal, ArS020R'5 and S02(0R'^)2 wherein Hal is a halogen atom (especially chlorine, bromine or iodine), R1^ is an alkyl group of 1 to 6 carbon atoms and Ar is an aromatic group which, for example, can be a phenyl or naphthyl group which in a given case is substituted by one or more lower alkyl groups. Examples are methyl chloride, ethyl bromide, methyl iodide, ethyl chloride, propyl bromide, isopropyl chloride, butyl chloride, butyl bromide, butyl iodide, sec. butyl chloride, sec. butyl bromide, t-butyl chloride, sec. butyl bromide, t-butyl chloride, amyl chloride, hexyl- chloride, heptyl chloride, methyl benzene sulfonate, ethyl benzene sulfonate, alkyl esters of p-toluene sulfonic acid such as methyl p-toluenesulfonate, ethyl p-toluenesulfonate, propyl p-toluene sulfonate, butyl p-toluene-sulfonate, isobutyl p-toluenesulfo-nate, hexyl p-toluenesulfonate, methyl 2,4-xylenesulfonate, methyl alpha naphthalenesulfonate, ethyl beta naphthalene sulfonate, lower dialkyl sulfates such as dimethyl sulfate, diethyl sulfate, dipropyl sulfate, dibutyl sulfate and the like. The alkylation can take place, in a given case with addition of customary acid binding agents such as bases, e.g. sodium hydroxide and potassium hydroxide, alkali carbonates such as sodium carbonate and potassium carbonate, alkali hydrides, e.g. sodium hydride, alkali amides, e.g. sodamine, alkali alcoholates, e.g. sodium methylate, potassium ethylate, sodium ethylate, sodium octylate, sodium decylate, pyridine or other conventional tertiary amines, e.g. dimethyl aniline, triethylamlne, or tributyl amine at a temperature between 0 and 150°C. in inert solvents such as alcohols, e.g. methyl alcohol, ethyl alcohol, propyl alcohol, isopropyl alcohol, butyl alcohol or amyl alcohol,dioxane, dimethyl formamide, dimethyl sulfoxide, aromatic hydrocarbons such as benzene, toluene or xylene or ketones such as acetone and methyl ethyl ketone (also see L.P. and Mary Fieser "Reagents for Organic Synthesis", John Wiley and Sons, Inc. New York, 1967, Vol 1, pages 1303-4; Vol. 2, page 471 and Vol. 3 (1972) page 349. ) The alkylation can also be carried out to introduce a lower alkyl group starting with a compound of formula I in which Rj| is hydrogen and is already present as the stated acyl group or as another easily splittable acyl group or, in a given case, a substituted benzyl group (the alkylation being suitably carried out as given above in the presence of a base or active alkali compound) and subsequently hydrolyzing off or hydrogenating off the R group by known methods (for example 5 as given below) .
As easily splittable groups there can be used, for example, the benzyl group, oC-phenylethyl group, benzyl groups substituted in the benzene nucleus as, for example, the p-bromo or p-nitrobenzyl group, the carbobenzoxy group, the carbobenzthio group, the trifluoroacetyl group, the phthalyl radical, the trityl radical, the p-toluenesulfonyl radical, the tert. butylcarboxy group and other protective groups used in the synthesis of peptides (see, for example Jesse P. Green-stein and Milton Winitz "Chemistry of Amino Acids", John Wiley and Sons, Inc. New York (1961) Vol. 2, pages 883 et seq.) The alkylation of the j^ and R^ containing amino group can 42007/2 ' 0-also be carried out by reacting a compound of formula I where R^ and R^ are hydrogen and the remaining groups R^, R2 and R^ are as defined above with an aliphatic aldehyde of 1 to 6 carbon atoms, e.g. formaldehyde, acetaldehyde, propionaldehyde acrolein, butyraldehyde, valeraldehyde, capraldehyde, metha-crolein or crotonaldehyde or an aliphatic ketone with 3 to 6 carbon atoms, e.g. acetone, methyl ethyl ketone, diethyl keton or methyl butyl ketone to form the corresponding Schiff 's bas and simultaneously or subsequently hydrogenating. These proces can be carried out at room temperature or elevated temperature in solvents such as aliphatic alcohols, e.g-. methyl alcohol, ethyl alcohol, propyl alcohol, isopropyl alcohol or butyl alcohol, alcohol water-mixtures, e.g. 6$ ethyl alcohol, dimethy forrnamide, or dimethyl formamide containing mixtures, etc. For the hydrogenation there can be used, for example, the usual hydrogenation catalysts such as platijum, palladium or nickel with or without carriers.
— O |l In case the radical R,_ is the group - C - Rg wherein g is a haloalkyl group, then this halogen atom can be exchanged for an amino or alkylamino group by reaction with ammonia or an aliphatic alkylamine having 1 to 6 carbon atoms in an organic solvent such as methanol,, ethanol or dioxane at a temperature between 0 and 150°C. An excess of amino compound is favorable to the reaction. 0 11 If the radical R,- signifies the group - C - g wherein Rg is an acylated amino group, this acyl group can be split off by selective saponification. There can be especially employed easily splittable acyl groups or in a given case substituted benzyl groups as are used in peptide chemistry such as those pointed out supra. This saponification can be carried out, for example, in water, methanol, ethanol, glacial acetic acid or mixtures of these or other solvents which contain the acid or base corresponding to that used for hydrolysis (e.g. potassium carbonate, sodium carbonate^ alkali, e.g sodium hydroxide or potassium hydroxide, ammonia, etc.). The temperature is between 20 and 150 C. Various acyl groups, as for example, the carbobenzoxy radical and the p-tolyloxycar-bonyl radical also can be split off by catalytic hydrogenation in the presence of customary hydrogenation catalysts, especially palladium catalysts in a solvent or suspension agent, in a given case under elevated pressure. As solvents or suspension agents there can be used, for example, water, lower aliphatic alcohols, e.g. methyl alcohol, ethyl alcohol or isoprop l alcohol, cyclic ethers such as dioxane or tetrahydrofurane, aliphatic ethers, e.g. diethyl ether or dipropyl ether, dimethyl formamide, etc. as well as mixtures of these materials. For splitting off there can be used all the methods employed in peptide and aminoacid chemistry for the removal of protective groups, see the Green-stein et al book cited above. Hydroxy or amino groups which are present can be correspondingly acylated by the conditions given with process (a) or they can be alkylated as given above.
Process (c) Process (c) is carried out suitably in a solvent such as methanol, ethanol, isopropanol, dioxane or tetrahydrofurane at temperatures between 0 and 150°C. The reduction can be carried out with hydrogen in the presence of metal catalysts such as Raney-nickel, Raney-cobalt or noble metal catalysts (palladium, platinum), in a given case on suitable carriers, et pressure of 1 to 100 atmosphere absolute.
If chemical reduction is employed there can be used nascent hydrogen with zinc, tin or iron and dilute acids, e.g. hydrochloric acid, aluminum amalgam/f^O or alkali hydrides or complex metal hydrides such as LiAUfy, LiH, sodium triethoyxy aluminum hydride, sodium dihydro bis(2-methoxyaluminate) and similar reducing agents or HgS, ammonium sulfide or alkali sulfides, e.g. sodium sulfide or potassium sulfide.
For the further reaction according to process (c) the solution resulting from the reduction can be' used directly without previous isolation of the amino compound, Basic compounds of formula I can be converted into their salts by known methods. As anions for these salts there can be used any of the known and therapeutically usable acid radicals such as those set forth above for example.
If the compounds of formula I contain acid groups then these can be converted in conventional manner into their alkali (e.g. sodium or potassium), ammonium or substituted ammonium salts. As substituted ammonium salts there may be especially noted salts o tertiary alkyl amines, lower aminoalcohols and bis and tris (hydrox alkyl) amines in which the alkyl radicals contain 1 to 6 carbon atoms such as triethylamine, ethanolamine,diethanolamine, triethano amine, propanolamine, dipropanolamine, trimethylamine, diethyl propyl amine, tributylamine, trihexylamine .
The free bases can be prepared again from the salts of the compounds in the usual manner, for example, by treating a solution in an organic solvent such as an alcohol (e.g. methanol) with soda or sodium hydroxide or by means of a dilute acid (for example dilute acetic acid).
- Il - Those compounds of formula I which contain asymmetric carbon atoms and as a rule result as racemates, can be split into the optically active isomers in known manner with the help of an optically active acid. However, it is also possible to employ from the beginning an optically active starting material whereby a correspondingly optically active or diastereomer form is obtained as the end product.
The compounds of the invention are suitable for the production of pharmaceutical compositions. The pharmaceutical compositions or medicaments can contain one or more of the compounds of the invention or mixtures of the same with other pharmaceutically active materials. For the production of pharmaceutical preparations there can be used the customary pharmaceutical carriers and assistan The medicines can be employed enterally, parenterally, orally or perlingually. For example, dispensing can take place in tire form of tablets, capsules, pills, drag&es, plugs, salves, jellies, cremes powders, liquids, dusts or aerosols. As liquids there can be used, for example, oily or aqueous solutions or suspensions, emulsions, injectable aqueous and oily solutions or suspensions.
Those starting materials for processes (a), (b) and (c) which are not known can be prepared in the following ways.
A compound of the formula or CHg - COgRa (V) where Ra is hydrogen or lower alkyl. It is first reacted with an active alkali compound such as sodamide, potassium amide, sodium hydride or finely divided sodium in an inert solvent such as dimethyl formamide, dioxane or benzene and then there is chopped in with stirring and in a nitrogen atomsphere the calculated amount of 2,6-dichloro-3-nitropyridine dissolved in the same solvent. In many cases it has proven also suitable to change the sequence of addition, for example, to add the alkali compound to a solution of phenylacetic acid or benzyl cyanide derivative and 2,6-dichloro-3-nltropyridine. The generally exothermic reaction results in the alkali salt of a compound of formula VI„ where Cy is CN or CC^ a, which salt is colored strongly blue or violet „ After the end of the reaction this is filtered off with suction, washed, dissolved in water and treated with diluted glacial acetic acid until disappearance of the intrinsic color. The compound of formula VI customarily crystallizes out in adequat purity.
As illustrative of this procedure 2-[alpha-cyano-)-o-chlorobenzyl]-3-nitro-6-chloropyridine was obtained as follows: To a solution of 120 grams of o-chlorobenzylcyanide in 1.5 liters of dioxane with stirring and in a nitrogen atmosphere there were added at 45°C. 42 grams of sodium hydride (8o in white oil). Then the mixture was stirred for 45 minutes at this temperature. It was then cooled and at 20 to 22°C. jthere were dropped in l40 grams of 2.6-dichloro-3-nitropyridine in 500 ml. of dioxane within 30 minutes. Reaction was allowed to continue for 3 hours at this temperature. The deeply colored sodium salt was filtered off with suction, washed with dioxane, dissolved in water/methanol (1:1 "by volume) and dilute acetic acid until change in color occurred. The desired compound crystallized out, was filtered off with suction and washed thoroughly with methanol.
M.P. 174 to 175°C.j Yield 91 grams.
From the compounds of formula VI the corresponding 2-benzoyl-3-nitro-6~chloropyridine derivations of formula VII can be obtained by oxidation. This can be accomplished, for example, with selenium dioxide in dioxane or tetrahydrofurane at 50 to 150°C. or it can also be accomplished with 30 hydrogen peroxide solution at temperatures below 100°C., preferably 20 to 50°C. in acetone-water wherein the stoichrometrical amount of an aqueous concentrated K0H solution is dropped in just quick enough that no color disappearance takes place. In the last procedure the chlorine atom in the 6 position to a large extent is simultaneously hydrolytically split off. Therefore there is isolated not only the desired compound but also a compound analogous to that of formula VII where R is OH. The latter can be again chlorinated in known manner with a mixture of whereby the PCI3 again deoxy- genates the N-oxide simultaneously formed as byproduct.
The nitro group in the compounds of formula VII is then reduced to the amino group either catalytically (with Pd, Pt, or Raney nickel in alcohols, e.g. methyl alcohol, ethyl alcohol or isopropyl alcohol, dioxane or tetrahydrofurane at 0 to 60°C. and at 1 to 50 atmospheres absolute) or chemically (with LiAlH^ or AI HgHgO, for example, in diethyl ether, dioxane or tetrahydrofurane between 0 to 100°C)e This amino group can then be alkylated with an alkyl group of 1 to 6 carbon atoms in the manner described previously.
Compounds of formula VIII le, by heating a compound of formula VII with a saturated aqueous alcoholic ammonia solution in an autoclave at 100 to 120°C. for several hours (2 to 4 hours) and then in known manner diazotizing the 6-amino-pyridine formed and reacting under the conditions of the Sandmeyer reactio or modified Sandmeyer reaction in the presence of fluoride or bromide ions and/or the corresponding copper (I) salts (Cu, Br, CuCl) or heating with fluoborate ions. As solvents there can be used -water-alcohol mixture or mixtures of water, dimethyl forma-mide and dimethyl sulfoxide. For the production of fluoro derivati the dry diazomine fluoborate can also be decomposed thermally.
Compounds of formula VIII in which R signifies a bromine atom- can also be prepared by brominating compounds of formula VIII in which R-^ is OH by use of a brominating agent such as POBr^, or SOB g, in a given case in an inert solvent, between 20 and 200°C. The production of compounds of formula VIII in which 1 is F can also take place in a modified manner in which there is gradually added NaNOg to a solution of a compound of formula VIII where R^ signifies amino in concentrated aqueous hydrofluoric acid at a temperature between 0 and 50°C, or else a slow stream of nitrous gases is led into such a solution.
The reduction of the nitro group as well as, in a given case, the subsequent introduction of R^ can take place in the mann already described.
For example, there are prepared compounds of formula I where ^ is chlorine, bromine or fluorine, Rg and R^ are in the -o and/or p-position, where Rg is chlorine, bromine, fluorine, or the methyl group and is hydrogen or a radical which is one of those indicated for R^ R4 is hydrogen or an alkyl group of 1 to 6 carbon atoms, especially 1 to 3 carbon atoms and R is hydrogen or an alkanoyl group with 2 to 8 carbon atoms, especially 2 to 4 carbon atoms, or an alkanoyl group of 2 to 8 carbon atoms, especially 2 to carbon atoms, which is substituted with 1 to 3 halogen atoms, especially fluorine or chlorine,- preferably in the alpha position (for example a haloacetyl group such as trifluoro- acetyl or fluoroacetyl) or an alkanoyl group of 2 to 8 carbon atoms, especially 2 to carbon atoms, substituted with an amino group, or a straight or branched chain alkanoyl group of 3 to 8 carbon atoms, especially 3 to 6 carbon atoms, or a carbalkoxy group of 2 to 8 carbon atoms, especially 2 to 5 carbon atoms (for example, the carbethoxy group, the carbamyloxy group, the carboctoxy group) or the benzoyl group or a benzoyl group substituted with halogen atoms or methyl groups ; in case R_ is an alkanoyl group substituted by the amino group or alk lamino group, the amino group is preferably present in the alpha position (for example the aminoacetyl group) wherein a hydrogen atom of this amino group can also be substituted by the carbophenosy radical, the carbobenzyloxy radical a carbalkoxy radical of 3 to carbon atoms, especially 3 carbon atoms or by an alkanoyl radical of- 2 to 4 carbon atoms (for example the acetyl radical or the propionyl radical).
Unless otherwise indicated all parts and percentages are by weight.
Example 1 75 grams of 2-benzoyl-3-nitro-6-chloropyridine in 500 ml of dioxane were hydrogenated with 20 grams of Raney nickel at 50 atmospheres absolute and 30 to 50°C. The filtered hydrogenated solution was evaporated in a vacuum and the residue recrystal-lized once from ethanol. Yield 2 grams, N.P. l60°C.
The starting material of example 1 was prepared in the following manner„ To a cooled and stirred solution of 190 grams of 2,6-dichloro-3-nitro-pyridine and 117 grams of benzyl cyanide in 2 liters of dioxane there was added gradually in a nitrogen atmospher 6 grams of sodium hydride (80 in white oil). The reaction mixture immediately became colored a deep dark blue, gradually a fine particled precipitate began to separate out, the temperature increased (with cooling with ice water) to 30°C. After 3 hours there were added about 20 ml of ethyl alcohol, stirring continuously for 20 minutes and then the mixture filtered with suction,, The deep blue sodium salt was dissolved in 1 liter of water and then treated with dilute acetic acid until the color disappeared,, The 2-(alpha-cyanobenzyl)-3~nitro-6-chloropyridine crystallized out in pure form. M.P. l65°Ce; Yield 146 grams.
A mixture of 200 grams of 2-(alpha-cyanobenzyl)-3-nitro -6-chloro yridine, 5-0 ml of acetone and 160 ml of 30 aqueous hydrogen peroxide solution with stirring were treated dropwise at 35 - 0°C. with a concentrated potassium hydroxide solution (made of 75 grams of K0H and 0 ml of water). The dropwise addition took place just quick enough that a disappearance of color did not take place. Immediately after a disappearance of color remained, which indicated the end of the reaction, the mixture was cooled and the crystalline material which separated was filtered off with suction. This material, the amount of which varies between 30 and 0 grams, is 2-benzoyl-3~nitro-6~chloro-pyridine which can be purified through recrystallization from methanol. M.P. 106oc. The filtrate was acidified with dilute hydrochloric acid, whereupon 2~benzoyl-3-nitro-6-hydroxy-pyridine precipitated out in an amount between 120 and l40 grams, M.P. 11°C.
This hydroxy compound was likewise converted into the desired 2-benzoyl-3-nitro-6-chloropyridine by chlorination. For this purpose 190 grams of 2-benzoyl™3-nitro-6-hydroxypyridine was ntlrred in a mixture of 200 ml of phosphorus trichloride, 500 ml. of phosphorus oxychloride and 190 grams of phosphorus pentachloride for hours at 72°C. Then the phosphorus halides were distilled off in a rotary evaporator in a vacuum, the residue taken up in 1 liter of chloroform and washed with ice water, twice with dilute sodium hydroxide and twice with water. The chloroform solution was dried, brought to dryness in a vacuum and the residue recrystallized from methanol. Yield 1¾5 grams; M.P. 106°C.
Example 2 2-(o-chlorobenzoyl)-3-amino-6-chloropyrldine 79 grams of 2-(o-chlorobenzoyl)~3~nitro-6-chloropyridine were hydrogenated in 500 ml of dioxane with 20 grams of Raney nickel at 50 atmospheres absolute at 30 to 50°C, the filtered hydrogenated solution was evaporated in a vacuum and residue recrystallized once from ethanol. Yield 55 grams; M.P. 170°C.
The starting material was made in a manner analogous to that employed in example 1 but starting from o-chlorobenzyl cyanide, .
Example 3 3 grams of 2-benzoyl-3-amino~6-chloropyridine were dissolved in 100 ml of dioxane, then ΐβ ml of pyridine and finally with stirring 18 ml of propionyl chloride were added. The mixture was stirred for 2 hours$ then water was added until crystallization began. The material which precipitated was recrystallized from methanol/water. Yield 8 grams; M.P. l40°CO Example 2-benzoyl-3-(3,3-dimeth 1-acryloylamino)~6-chloropyridine eiOs grams of 2-benzoyl-3~amino-6-chloropyridine and 1 v grams of 3, 3-dimethyl acryloyl chloride were stirred for 2 hours in 100 ml of dioxane and 9.5 ml of pyridine and then treated with water until crystallization began. The precipitated material was recrystallized from methanol-water. Yield 23 grams; M.P. 168°C.
Example 5 2-benzoyl-3-carbethoxyamino-6-chloropyridine 30 grams of 2-benzoyl -3~ainino-6-chloropyridine and 20 grams of ethyl chloroformate were stirred for 2 hours in 100 ml of diozane and 20 ml of pyridine and then treated with water until crystallization began. The precipitated material was re-crystallized from methanol-water0 Yield 32 grams; M.P. 98°C.
Example 6 2- enzo 1 -3-benzo lamino -6-chlorop ridine 11.5 grams of 2-benzoyl-3-amino-6-chloropyridine and 7 grams of benzoyl chloride were stirred for 2 hours in 100 ml of dioxane and 16 ml of pyridine and then treated with water until crystallization began. The precipitated material was recrystallized from raethanol-water. Yield 11 grams; M.P." 146 to l 7°C.
Example 7 2-benzoyi-3rbenzyloxycarbonylaminoacetamino-6-chloropyridine 21 grams of N-benzyloxycarbonyl glycine were suspended ±nlH'i}jsl of ether and 21 grams phosphorus pentachloride added with stirring. A clear solution formed. After 30 minutes there were added a solution of 23 grams of 2~benzoyl-3-amino~6-chloro-pyridine in .whereupon a weak exothermic reaction occurred. The mixture was stirred for 2 hours at room temperature, the precipitate which crystallized out was filtered off with suction and subsequently washed with ether. Yield 30 grams M.P, 130°C.
Example 8 2-benzoyl-3-aminoacetamino~6-chloropyridine 29 grams of 2~benzoyl-3-benzyloxycarbonylaminoacetamino -6-chloropyridine were added in portions to 120 ml of a 3C$ crystallization began. The precipitated material v/as recrystallized from methanol-water. Yield 11 grams; M.P. 146 to l 7°C.
Example 7 2- enzoyi-3- enz loxycarbonylaminoacet mino-6-chlorop ridlne 21 grams of N-benzyloxycarbonyl glycine were suspended in ml of ether and 21 grams phosphorus pentachloride added with stirring. A clear solution formed. After 30 minutes there were added a solution of 23 grams of 2~benzoyl-3-amino-6-chloro-pyridine in ml of whereupon a weak exothermic reaction occurred. The mixture was stirred for 2 hours at room temperature, the precipitate which crystallized out was filtered off with suction and subsequently washed with ether. Yield 30 grams Example 8 2-benzoyl-3-aminoacetamino-6-c.hloropyridine 9 grams of 2-benzoyl-3-benzyloxycarbonylaminoacetamino -6-chloropyridine were added in portions to 120 ml of a 30$ - 25 - solution of HBr in 99 glacial acetic acid at -5 to 0°C. The portions went into solution with strong development of COg. After 15 minutes about 50 ml of dry ether were added. The precipitated material was filtered off with suction after 30 minutes and washed with ether. Yield 50 grams; M.P. of the hydrobromide 250°C.
Example 9 2-benzoyl-3~ (propionyl-methylamino) -6-chloropyridine grams of 2-benzoyl~3~propionylamino-6~chloropyridine (prepared as in example 3 ) were dissolved in 200 ml of dimethyl formamidej with stirring and in a nitrogen atmosphere there were added 5.5 grams of 80$ sodium hydride in white oil; after 30 minutes there were dropped in 29 ml of methyl iodide and the mixtur stirred for 2 hours at 50°C. Then there were added 10 ml of methan and the mixture evaporated in a vacuum. The compound came out as an oil.
Example 10 2~benzoyl-3-methylamino-6-chloropyridine - 26 - 50 grams of 2-benzoyl-3**(proplonyl-methylamino)-6-chloro-pyridine were taken up in 100 ml of ethanol. 200 ml of water and 200 ml of concentrated hydrochloric acid were added. The mixture was heated at reflux for 10 hours and then treated with 1 liter of water. The syrup which precipitated crystallized after rubbing for some time. The material was recrystallized from ethanol.
Yield 2k grams; M.P. 77°C.
Example 11 2-(o-chlorobenzoyl)-3-acetamino-6-chlorop ridine 70 grams of 2-(o-chlorobenzoyl)-3~amino-6~chloropyridine in 500 ml of dioxane were treated with 26 ml of pyridine and 73 ml of acetyl chloride and stirred for 1 hour. Water was added until turbidity occurred, whereupon the reaction product crystallized out and this was recrystallized from ethanol. Yield 63 grams; M.P. 132°C.
Example 12 2-(o-chlorobenzoyl)-3-benzyloxycarbonyl~a-ninoacetamino 6--chloro - 27 - 2 grams of benzyloxycarbonyl glycine were suspended in 200 ml of dry dioxane and 27 grams of PCl^ added. To this solution there were added 3½ grams of 2-(o-chlorobenzoyl)-3-amino-6-chloropyridine and stirred for another hour. Subsequently the mixture was treated with petroleum ether until there was complete precipitation of the reaction product. Yield 50 grams; M.P. 105°C.
Example 13 2-(o-chlorobenzoyl)~3-aminoacetamino-6-chloropyridine 50 grams of 2-(o-chlorobenzoyl)-3-benzyloxycarbonylamino-acetamino-6-chloropyridine were added portionwise at 0°C. to 100 ml of 99$ acetic acid saturated with HBr whereupon a strong developmen of C02 occurred. After 1 hour of stirring the mixture was treated with ether until turbidity developed. Yield 35 grams; the hydro-bromide melted at 210°C. (decomposition).
Example l 2- (o-fluorobenzoyl)-3-amino-6-chloropyridine 49 grams of 2-(o-fluorobenzoyl)-3- nitro-6-chloro-pyridine were hydrogenated in 500 ml of dioxane with addition of 10 grams of Raney nickel at a hydrogen pressure of 40. atmospheres absolute and a temperature of 40 to 60°C. The filtered hydrogenated solution was concentrated in a vacuum to about 100 ml whereupon the reaction product crystallized out. It was recrystallized from ethanol.
Yield 36 grams; M.P. 180 to 181°C.
The starting material was m- de in a manner analogous to that employed in example 1 but starting from o-fluorobenzyl cyanide.
Example 15 2-Benzoyl-3-chloroacetamido-6-chloropyridine 140 grar;s of 2-Benzoyl-3-arcino-6-chloropyrid ine were added in portions to a mixture of 55 m of chloroacetyl chloride and 3 0 ml dioxane under continous stirring. Stirring was continued for another hour and the reaction mixture was then treated with 200 ml of ethanol and 400 ml of benzine. The precipitated compound was filtered off with suction and re-crystallyzed from alcohol.
Yield 140 grams; K.P. 140-142°C.
Example 16 2-Benzoyl-3-bromoacetamido-6-chloropyridine To a solution of 312 grams of 2-benzoyl-3-S-Eino-6-chloropyridine in 1250 ml of acetone were added dropwise during 15 minutes 135 ml of bromoacetylchloride and the mixture was cooled with ice. After some time the reaction product crystallized and VPS suctioned off after 2 hours.
Yield 363 grams; M.P. 12B°C Example 17 2-( o-Chlorobenzcyl)-3-trifluoroacetylamino-6-chloropyridine 134 grams of 2-( o-chlorobenzoyl )-3-amino-6-chloro-pyridine were suspended in 200 ml of chloroform, and trifluoro-acetic acid anhydride was added dropwise under ccntinous stirring at 30 -.35°C. After 30 minutes of further stirring the solution thus obtained was evaporated to dryness and the residue recrystallized from ethanol.
Yield 147.5 grams; M.P. 14S°C.
Example 18 2-(-o-Chlorobenzcyl)-3-( -chlorobenzoylamino )-6-chlorop ridine 26,7 grams of 2-( o-chlorobenzoyl )-3-amino-6-chloro-pyridine were dissolved in 100 ml of dioxane under addition of 9 ml of pyridine, and then19.3 grams of o-ehlorobenzoyl ^ chloride were added under continous stirring. After 2 hours the solution was filtered, water was added until crystallization occurred and the precipitate was filtered by suction. The product was recrystallized from dioxane.
Yie-Ld 25 grams; M.P. 215-217°C Example 19 2-( o-Fluorobenzoyl)-3-(p-chlorobenzoylamino)-6-chloropyridine The compound is prepared in a manner as discussed in Example 18, starting from 26 grams of 2-( o-fluorobenzoyl)-3-an,ino-6-chloropyridine.
Yield 22 grams ;M.P. 203-205°C.
Example 20 2-£>enzoyl-3-(ai--inoacetair.ino )-6-chlorop ridine 100 grams of 2-benzoyl-3-bromoaceta;i ino-6-chloro-pyridine were added under continous stirring to 400 ml of liquid ammonia. The mixture was stirred at -40°C for 4 hours, then the ammonia was evaporated off. The solid residue was dissolved in' 400 ml of methylene chloride and the solution was washed once with 400 ml of water. '-The organic phase was dried and treated under continous stirring with 400 ml of benzene, whereby the desired product precipitated.
Yield 50 grame; M.P. 200-201°G.
The starting material was prepared as follows.
To a solution of 312 grams of 2-benzoyl-3-asiino-6-chloropyridine in 1250 ml of acetone there was added during 1 minutes 135 ml of bromoacetylchloride under cooling v.'ith ice. After some time the r action product crystallized and was ■filtered by auction after 2 hours..
Yield '6 grams; M.P. 128°C.
Example 21 2-Bensoyl-3-( " th lamino-acetan.ido)-6-chloropyridine II II Into a mixture of 0 grams of ethylamine and 150 ml methanol there was added at room temperature 34.4. grams of 2-benzoyl-3-bromoacetamido-6-chloropyridine under continous stirring, Aft< r a temporary decrease in temperature, the temperature -raised "again to 30°C. The crystal] ine · substance formed after one hour of stirring was filtered by suction, dissolved in dioxane, and treated with 6n ethanolic hydrochloric acid solution. The salt thus formed was filtered by suction and washed with dioxane.
Yield 23.8 grams; M.F. 196-200°C (hydrochloride) Example 22 (production by means of acid anhydride^. 2-Benzoyl-3-proprionylamino-6-chloropyridine H For obtaining this compound the procedure used in · Example 3, is applied, but instead of 18 ml of propionylchloride, 25 grams of propionic acid anhydride ere used.
Yield 40 grams; M.P. 130°C.
Example 23 2-( o-i^ethylbenzoyl)-3-amino-6-chloropyridine. 15 grams of 2-( o-methylbenzoyl )-3-nitro-6-chl oro-pyridine in 300 ml of dioxane were hydrogenated by means of 5 grams of Raney-nickel at 85°C and 50 atmospheres of hydrogen.
The solution was separated from the catalyst by filtration, poured into 1. litre of water and the-precipitated crystals were filtered off by suction. Pure crystals were obtained.
Yield 11 grams; K.P. 164-16 °C The starting material may be produced in a manner analogous to that of Example.1.
Example 24 -Chiorobenzo 1)-3-meth laminc-6-chloropyridine H 134 grams of 2-( o-chlorobenzoyl )-3-aicinc-6-chloro- pyridine were suspended in 200 ml of chloroform and trifluoro acetic acid anhydride was added dropwise under continous stirring at 30-35°C After 30 minutes of additional stirring the solution thus obtained was evaporated to dryness and the residue was re- crystallized from ethanol.
Yield 147.5 grams.14. P. 148°C.
A mixture of 158 grams of the thus obtained 2-(chloro- benzo l)-3- rifluoroacetyl&mino-6-chlorop ridine, .247 grams methyliodide and 1500 ml of acetone were heated under stirring to 48°C, then during 5 minutes, 97.5. rams of powdered KOH were jadded and at the same time the mixture was cooled with water so that the temperature did not exceed 50°C. The solvent was then evaporated in vacuo, and the residue was mixed with 660 ml of ethanol/water mixture (lo:l) whereby the reaction product separated in the form of crystals. After 2 hours =the crystals vere filtered off by suction and the product was recrystallized from 600 ml of n-propanol.
Yield 99 grams; M.P. 149°C. , Example 25 -FluorObenzoyl)-3-meth lamino-6-chloroFyrid H A mixture of 68 grams of 2-(o-fluorobenzoyl)-3-trifluoroacc tylamiho-6-chloropyridine (produced in a manner analogous to that of the preceeding -kxaniple from 50 grams of 2-( o-fluorobenzoyl-3-amino-6-chloropyridine ) f 116 grams of methyliodide , 700 ml of acetone was treated as in the pre-ceeding xam le with KOH and the precipitated and separated as in the preceeding -Example..
Yield 39 grams; .P. 148°C. --.xample 26 2-Benzoyl-3-butylamino-6-chloropyridine To a solution of 140 grams of 2-benzoyl-3-a ino-6-chloropyridine in 900 ml of dime thyIforrcamid e there were added under continous stirring at 30-4C°C 20 grams of sodium hydride in white oil (80 ) and after 30 minutes 80 ml of butyliodide are added dropwise. ¾e mixture was kept 5 hours at 80-90^0, then 100 ml of ethanol were added and after a short period of stirring the solvent was evaporated in vacuo, The residue was purified over silica gel by dry chromatogra hy (elution with 42007/2 The compounds of the invention are suited for the production of pharmaceutical compositions and preparations. The pharmaceutical compositions or drugs contain as the active material one or several o the compounds of the invention, in a given case in admixture with other pharmacologically or pharmaceutically effective materials. The production of the medicine can take place with the use of known and customary pharmaceutical carriers and diluents, as well as other customary carriers and assistants.
Such carriers and assistants are set forth, for example, in Dllmann's Encyklopa'die der technischer Cheraie, Vol. (1953 ) 3 pages 1 to 39; Journal of Pharmaceutical Sciences, Vol. 2 (1963 ) , pages 918 et seq; H. v. Czetsch-Lindenwald, Hilfstoffe fi!ir Pharmazie und angrenzende Gebiete; as well as in Pharm. 2nd Vol. 2 (1961) pages 72 et seq.; Dr. H.P. Fiedler, Lexicon der Hilfstoffe filr Pharmazie, Kosmetik und angrenzende Gehiete, Cantor geAulendorf i. Wurtt, 1 71. - 29 g - !Ehe coarse lactose powder, the microcrystalline cellulose and the magnesium stearate are mixed and then passed through a sieve having holes of 0,5 am (Mixture I).
Mixture I is placed together with the active compound in a mixer for intense mixing ( or example a Lodige fflixer) and mixed until homogenous distribution of the active compound is reached (Mixture II) fee mixture IX is placed in unit doses of 260 mg into hard gelatine capsules (of the Snap-fit type, size 2).
On such capsule contains 5 mg of active material. 29 42007/3
Claims (9)
1. To 3 halogen atoms as substituents , lower alkenyl , aminolower alkyl or alkylaminoalkyl haVing 2 to 13 carbon atoms or where any primary or secondary amino group has the hydrogen replaced by an alkanoyl group of 2 to 8 carbon atoms, carbalkoxy having 1 to 6 carbon atoms in the alkoxy group or carbobenzyloxy and pharmacologically acceptable salts of such compounds.
2. Compounds of formula I In Claim 1 wherein , H2 and have the same nseanings as in Claim 1 , is hydrogen and is hydrogen, a lower alkyl or benzoyl 11. .73 for claims grou or a group 2 to 8 in which R is lower alkyl* aonohalosubstituted lover alkyl, aninoalkyl in which the amine group stay be substituted with a C2~% alkanoyl group or with a carbobenzyloxy group, and salts thereof. /
3. - Pyridine compounds according to Claim 1 , wherein is halogen of an atomic weight of 9 to 80, R2 and R^ are hydrogen, halogen of atomic weight 9 to 80 or alkyl or 1 to 6 carbon atoms, R^ is hydrogen or alkyl of 1 to 6 carbon atoms, R^ is hydrogen, alkyl of 1 to 6 carbon atoms, benzoyl optionally substituted with 1 to 3 halogens of atomic weight 9 to 80, carbalkoxy of 2 to 6 carbon atoms - C - Sg where Rg is alkyl of 1 to 7 carbon atoms optionally substituted with 1 to 3 halogen atoms of atomic weight 9 to 80, alkenyl of 2 to 7 carbon atoms, aminoaikyl having 1 to 7 carbon atoms or alkyl-aminoalkyl having 2 to 13 carbon atcms, or ¾here - ' ;·" , primary or secondary amino group has the hydrogen replaced by an alkanoyl group of 2 to 8 carbon atoms, carbalkoxy having 1 to 6 carbon atoms in the aikoxy group or carbobenzyloxy and pharmacologically acceptable salts of such pyridine compounds,
4. · Pyridine compounds according to Claim 3 wherein Rj is chlorine, Έί^ is hydrogen, chlorine or fluorine, R^ is hydrogen, R^ is hydrogen or methyl, R^ is hydrogen, methyl or 0 - b - Hg where Rg is alkyl of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, aikoxy of 1 to 4 carbon atoms, phenyl,- aminoaethyl, benzyloxycarbonylamino-methyl.
5. '· Pyridine compounds according to Claim 1 wherein 0 - C - Hg is alkanoyl of 1 to 8 carbon atoms, having 1 to 3 halogen atoms of atomic weight 9 to 80 as substit ents, - alkenoyl of 3 to 8 carbon atoms, aminoalkylene carbonyl of 2 to 8 carbon atoms, alkylaminoalkylene carbonyl of 2 to 14 carbon atoms, carbalkoxy of 2 to 7 carbon atoms or carbobenzyloxy»
6. Pyridine compounds according to Claim 1 wherein R^ is chlorine, Rg is hydrogen or halogen of atomic weight 9 to 80, is hydrogen, R^ is hydrogen or alkyl with 1 to 3 carbon atoms and B.^ is hydrogen, alkanoyl or 2 to 4 carb atoms, alkenoyl of 3 to 5 carbon atoms, haloacetyl where the halogen has an atomic weight of 9 to 80, aminoacetyl^ carbmethoxy,carbethoxy or benzoyl*
7. » Pyridine compounds according to Claim 6 wherein ^ is hydrogen, chlorine or fluorine, R^ is hydrogen or methyl and R^ is hydrogen, acetyl, propionyl, chloroacetyl bromoacetyl or aminoacetyl*
8. · Pyridine compounds of formula I in Claim 1 , substantially as described herein with reference to the Examples·
9. Pharmaceutical compositions comprising as an active ingredient a compound of formula - 32 ~ wherein R¾ is halogen, R2 and R^ are hydrogen, halogen or lower alkyl; R. is hydrogen or lower alkyl, and Rc is hydrogen, lower alkyl, benzoyl, halo substituted benzoyl, lower carbalkoxy or ? . . ·, . Q R where Rg is lower "" 6 alkyl, lower alkyl having 1 to 3 halogen atoms as sub stituents, lower alkenyl, aminolower alkyl or alkylamino-alkyl having 2 to 13 carbon atoms or where any „" v- primary or secondary amino group has the hydrogen replaced by an alkanoyl group of 2 to 8 carbon atoms, carbalkozy havin 1 to 6 carbon atoms i the alkoxy group or carbobenzyloxy or a pharmacologicall acceptable salt thereof. Farthe \Applicants DR. REINHOLD SOHN AND PARTNERS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT411372A AT321303B (en) | 1972-05-10 | 1972-05-10 | Process for the preparation of new 2-benzoyl-3-aminopyridine compounds and their salts |
Publications (2)
Publication Number | Publication Date |
---|---|
IL42007A0 IL42007A0 (en) | 1973-06-29 |
IL42007A true IL42007A (en) | 1977-06-30 |
Family
ID=3559825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL42007A IL42007A (en) | 1972-05-10 | 1973-04-11 | 2-benzoyl-3-amino-pyridines |
Country Status (23)
Country | Link |
---|---|
US (1) | US3875176A (en) |
JP (1) | JPS4948674A (en) |
AR (2) | AR207633Q (en) |
AT (1) | AT321303B (en) |
AU (1) | AU469111B2 (en) |
BE (1) | BE799339A (en) |
CA (1) | CA991189A (en) |
CH (2) | CH605761A5 (en) |
CS (1) | CS181238B2 (en) |
DD (1) | DD106378A5 (en) |
DE (1) | DE2319872A1 (en) |
EG (1) | EG11137A (en) |
ES (3) | ES413174A1 (en) |
FR (1) | FR2184077B1 (en) |
GB (1) | GB1416459A (en) |
HU (1) | HU169037B (en) |
IL (1) | IL42007A (en) |
NL (1) | NL7306170A (en) |
PL (1) | PL91935B1 (en) |
RO (1) | RO63441A (en) |
SE (1) | SE415974B (en) |
SU (4) | SU538662A3 (en) |
ZA (1) | ZA732013B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4007290A (en) * | 1974-01-09 | 1977-02-08 | General Foods Corporation | Caffeine antagonim |
ATE7295T1 (en) * | 1980-01-16 | 1984-05-15 | Lacer, S.A. | 2-HALO-PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS. |
JPH01104580U (en) * | 1988-01-05 | 1989-07-14 | ||
JP2531989B2 (en) * | 1988-09-14 | 1996-09-04 | 吉富製薬株式会社 | Pyridine compound |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3781360A (en) * | 1966-01-14 | 1973-12-25 | Schering Corp | 2-polyfluoroloweralkylamino benzophenones |
US3763178A (en) * | 1968-09-05 | 1973-10-02 | American Home Prod | Imidazolinyl phenyl carbonyl acid addition salts and related compounds |
-
1972
- 1972-05-10 AT AT411372A patent/AT321303B/en not_active IP Right Cessation
-
1973
- 1973-01-01 AR AR251133A patent/AR207633Q/en unknown
- 1973-03-22 ZA ZA732013A patent/ZA732013B/en unknown
- 1973-03-27 DD DD169761A patent/DD106378A5/xx unknown
- 1973-03-30 ES ES413174A patent/ES413174A1/en not_active Expired
- 1973-03-30 ES ES413173A patent/ES413173A1/en not_active Expired
- 1973-03-30 ES ES413175A patent/ES413175A1/en not_active Expired
- 1973-04-03 US US347361A patent/US3875176A/en not_active Expired - Lifetime
- 1973-04-11 IL IL42007A patent/IL42007A/en unknown
- 1973-04-19 DE DE2319872A patent/DE2319872A1/en not_active Withdrawn
- 1973-04-26 SU SU1914703A patent/SU538662A3/en active
- 1973-05-03 NL NL7306170A patent/NL7306170A/xx not_active Application Discontinuation
- 1973-05-07 CH CH381676A patent/CH605761A5/xx not_active IP Right Cessation
- 1973-05-07 CH CH643373A patent/CH582150A5/xx not_active IP Right Cessation
- 1973-05-08 PL PL1973162405A patent/PL91935B1/pl unknown
- 1973-05-08 CS CS7300003271A patent/CS181238B2/en unknown
- 1973-05-08 EG EG168/73A patent/EG11137A/en active
- 1973-05-09 BE BE6044150A patent/BE799339A/en unknown
- 1973-05-09 RO RO7300074727A patent/RO63441A/en unknown
- 1973-05-09 HU HUDE817A patent/HU169037B/hu unknown
- 1973-05-10 SE SE7306625A patent/SE415974B/en unknown
- 1973-05-10 FR FR7316947A patent/FR2184077B1/fr not_active Expired
- 1973-05-10 JP JP48052056A patent/JPS4948674A/ja active Pending
- 1973-05-10 AR AR247950A patent/AR201105A1/en active
- 1973-05-10 CA CA170,937A patent/CA991189A/en not_active Expired
- 1973-05-10 GB GB2229873A patent/GB1416459A/en not_active Expired
- 1973-05-10 AU AU55537/73A patent/AU469111B2/en not_active Expired
-
1974
- 1974-06-17 SU SU742043814A patent/SU597338A3/en active
- 1974-07-17 SU SU2043813A patent/SU561508A3/en active
- 1974-07-17 SU SU742043816A patent/SU677653A3/en active
Also Published As
Publication number | Publication date |
---|---|
AU469111B2 (en) | 1976-02-05 |
CA991189A (en) | 1976-06-15 |
NL7306170A (en) | 1973-11-13 |
BE799339A (en) | 1973-11-09 |
US3875176A (en) | 1975-04-01 |
FR2184077B1 (en) | 1976-07-02 |
JPS4948674A (en) | 1974-05-11 |
DE2319872A1 (en) | 1973-11-22 |
ES413174A1 (en) | 1976-01-16 |
AT321303B (en) | 1975-03-25 |
SU677653A3 (en) | 1979-07-30 |
ZA732013B (en) | 1974-04-24 |
DD106378A5 (en) | 1974-06-12 |
CH582150A5 (en) | 1976-11-30 |
AR207633Q (en) | 1976-10-22 |
CS181238B2 (en) | 1978-03-31 |
CH605761A5 (en) | 1978-10-13 |
ES413173A1 (en) | 1976-01-16 |
RO63441A (en) | 1978-05-15 |
PL91935B1 (en) | 1977-03-31 |
FR2184077A1 (en) | 1973-12-21 |
GB1416459A (en) | 1975-12-03 |
AU5553773A (en) | 1974-11-14 |
SU538662A3 (en) | 1976-12-05 |
SU561508A3 (en) | 1977-06-05 |
HU169037B (en) | 1976-09-28 |
SE415974B (en) | 1980-11-17 |
ES413175A1 (en) | 1976-06-01 |
AR201105A1 (en) | 1975-02-14 |
EG11137A (en) | 1978-06-30 |
SU597338A3 (en) | 1978-03-05 |
IL42007A0 (en) | 1973-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0260817B1 (en) | Quinazolinediones and pyridopyrimidinediones | |
EP0492485B1 (en) | N-Acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same | |
EP0119161B1 (en) | Benzazocinone and benzazoninone derivatives, process for their preparation, pharmaceutical preparations containing these compounds, and their therapeutical use | |
DE3700408A1 (en) | Indole derivatives, pharmaceutical preparations containing them and processes for their preparation | |
US3796723A (en) | Cyclodopa derivatives | |
EP1124797B1 (en) | N-arylsulfonyl amino acid omega amides | |
US4124593A (en) | Aromatic dicarboximides | |
US3941883A (en) | Aromatic dicarboxamides as anticonvulsants | |
US4404214A (en) | 2-Pyridinecarboxamide derivatives compositions containing same and method of using same | |
IL42007A (en) | 2-benzoyl-3-amino-pyridines | |
AU624978B2 (en) | N,n'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamides, preparation and their use | |
US4797403A (en) | Quinazolinediones and pyridopyrimidinediones | |
TW414791B (en) | Process and intermediates for preparing naphthyridonecarboxylic acid salts | |
JPH037280A (en) | Novel benzothiopyranylamine | |
DE2017470A1 (en) | ||
AT234103B (en) | Process for the preparation of new, benzylindolyl-substituted lower aliphatic acids and their salts and esters | |
US3998811A (en) | Optically active 1,4-benzodiazepines and process for the preparation thereof | |
US3969361A (en) | 2-Benzoyl-3-amino-pyridines | |
US4045569A (en) | Optically active 1,4-benzodiazepines and process for use as a tranquilizer | |
US4012397A (en) | 2-Benzoyl-3-amino-pyridines | |
Moore et al. | Heterocyclic Studies. V. Proof of Structure and Synthesis of 3-Hydroxy-4-methyl-5-phenylpyridine, A Degradation Product of 2, 3-Dihydro-5-methyl-6-phenyl-4H-1, 2-diazepin-4-one1 | |
PL89682B1 (en) | New 6-aza-3h-1,4-benzodiazepines[au4993172a] | |
JPS6040420B2 (en) | 3-Amino-2-(5-fluoro- and 5-methoxy-1H-indol-3-yl)propanoic acid derivatives, their preparation and use | |
US4285938A (en) | 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives | |
JPS5913766A (en) | Novel 1-phenyl-2,4-benzodiazepine derivative and its preparation |